Novo Nordisk to enter RNA market with Dicerna purchase
Denmark's Novo Nordisk, the world's leading insulin maker, has revealed it will buy US-based Dicerna Pharmaceuticals, a developer of RNA...
Novo Nordisk to enter RNA market with Dicerna purchase
Researchers uncover subset of cerebellar neurons signalling satiation
Obesity increases the risk of gum disease
Why obesity increases risk of cardiovascular complications in COVID-19
We’re not acting fast enough against diabetes and obesity
Stigma and shame by medical professionals might be as damaging as as obesity itself
The time to have a less conservative approach to the current obesity treatment is now